401 related articles for article (PubMed ID: 18549878)
1. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization.
Nakamoto N; Kaplan DE; Coleclough J; Li Y; Valiga ME; Kaminski M; Shaked A; Olthoff K; Gostick E; Price DA; Freeman GJ; Wherry EJ; Chang KM
Gastroenterology; 2008 Jun; 134(7):1927-37, 1937.e1-2. PubMed ID: 18549878
[TBL] [Abstract][Full Text] [Related]
2. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade.
Nakamoto N; Cho H; Shaked A; Olthoff K; Valiga ME; Kaminski M; Gostick E; Price DA; Freeman GJ; Wherry EJ; Chang KM
PLoS Pathog; 2009 Feb; 5(2):e1000313. PubMed ID: 19247441
[TBL] [Abstract][Full Text] [Related]
3. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression.
Radziewicz H; Ibegbu CC; Fernandez ML; Workowski KA; Obideen K; Wehbi M; Hanson HL; Steinberg JP; Masopust D; Wherry EJ; Altman JD; Rouse BT; Freeman GJ; Ahmed R; Grakoui A
J Virol; 2007 Mar; 81(6):2545-53. PubMed ID: 17182670
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction.
Golden-Mason L; Palmer B; Klarquist J; Mengshol JA; Castelblanco N; Rosen HR
J Virol; 2007 Sep; 81(17):9249-58. PubMed ID: 17567698
[TBL] [Abstract][Full Text] [Related]
5. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection.
Penna A; Pilli M; Zerbini A; Orlandini A; Mezzadri S; Sacchelli L; Missale G; Ferrari C
Hepatology; 2007 Mar; 45(3):588-601. PubMed ID: 17326153
[TBL] [Abstract][Full Text] [Related]
6. Bim-mediated apoptosis and PD-1/PD-L1 pathway impair reactivity of PD1(+)/CD127(-) HCV-specific CD8(+) cells targeting the virus in chronic hepatitis C virus infection.
Larrubia JR; Benito-Martínez S; Miquel J; Calvino M; Sanz-de-Villalobos E; González-Praetorius A; Albertos S; García-Garzón S; Lokhande M; Parra-Cid T
Cell Immunol; 2011; 269(2):104-14. PubMed ID: 21481848
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.
Raziorrouh B; Ulsenheimer A; Schraut W; Heeg M; Kurktschiev P; Zachoval R; Jung MC; Thimme R; Neumann-Haefelin C; Horster S; Wächtler M; Spannagl M; Haas J; Diepolder HM; Grüner NH
Gastroenterology; 2011 Oct; 141(4):1422-31, 1431.e1-6. PubMed ID: 21763239
[TBL] [Abstract][Full Text] [Related]
8. HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression.
Vali B; Jones RB; Sakhdari A; Sheth PM; Clayton K; Yue FY; Gyenes G; Wong D; Klein MB; Saeed S; Benko E; Kovacs C; Kaul R; Ostrowski MA
Eur J Immunol; 2010 Sep; 40(9):2493-505. PubMed ID: 20623550
[TBL] [Abstract][Full Text] [Related]
9. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B.
Fisicaro P; Valdatta C; Massari M; Loggi E; Biasini E; Sacchelli L; Cavallo MC; Silini EM; Andreone P; Missale G; Ferrari C
Gastroenterology; 2010 Feb; 138(2):682-93, 693.e1-4. PubMed ID: 19800335
[TBL] [Abstract][Full Text] [Related]
10. Unraveling the role of PD-1/PD-L interactions in persistent hepatotropic infections: potential for therapeutic application?
Radziewicz H; Hanson HL; Ahmed R; Grakoui A
Gastroenterology; 2008 Jun; 134(7):2168-71. PubMed ID: 18486616
[No Abstract] [Full Text] [Related]
11. Costimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis C.
Larrubia JR; Benito-Martínez S; Miquel J; Calvino M; Sanz-de-Villalobos E; Parra-Cid T
World J Gastroenterol; 2009 Nov; 15(41):5129-40. PubMed ID: 19891011
[TBL] [Abstract][Full Text] [Related]
12. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
[TBL] [Abstract][Full Text] [Related]
13. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
[TBL] [Abstract][Full Text] [Related]
14. Transient CD86 expression on hepatitis C virus-specific CD8+ T cells in acute infection is linked to sufficient IL-2 signaling.
Radziewicz H; Ibegbu CC; Hon H; Bédard N; Bruneau J; Workowski KA; Knechtle SJ; Kirk AD; Larsen CP; Shoukry NH; Grakoui A
J Immunol; 2010 Mar; 184(5):2410-22. PubMed ID: 20100932
[TBL] [Abstract][Full Text] [Related]
15. Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver.
Bengsch B; Spangenberg HC; Kersting N; Neumann-Haefelin C; Panther E; von Weizsäcker F; Blum HE; Pircher H; Thimme R
J Virol; 2007 Jan; 81(2):945-53. PubMed ID: 17079288
[TBL] [Abstract][Full Text] [Related]
16. Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection.
Missale G; Pilli M; Zerbini A; Penna A; Ravanetti L; Barili V; Orlandini A; Molinari A; Fasano M; Santantonio T; Ferrari C
Gut; 2012 Jul; 61(7):1076-84. PubMed ID: 22337949
[TBL] [Abstract][Full Text] [Related]
17. Impaired hepatitis C virus (HCV)-specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infection.
Radziewicz H; Ibegbu CC; Hon H; Osborn MK; Obideen K; Wehbi M; Freeman GJ; Lennox JL; Workowski KA; Hanson HL; Grakoui A
J Virol; 2008 Oct; 82(20):9808-22. PubMed ID: 18667503
[TBL] [Abstract][Full Text] [Related]
18. Factors that determine the antiviral efficacy of HCV-specific CD8(+) T cells ex vivo.
Seigel B; Bengsch B; Lohmann V; Bartenschlager R; Blum HE; Thimme R
Gastroenterology; 2013 Feb; 144(2):426-436. PubMed ID: 23142136
[TBL] [Abstract][Full Text] [Related]
19. High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome.
Kasprowicz V; Schulze Zur Wiesch J; Kuntzen T; Nolan BE; Longworth S; Berical A; Blum J; McMahon C; Reyor LL; Elias N; Kwok WW; McGovern BG; Freeman G; Chung RT; Klenerman P; Lewis-Ximenez L; Walker BD; Allen TM; Kim AY; Lauer GM
J Virol; 2008 Mar; 82(6):3154-60. PubMed ID: 18160439
[TBL] [Abstract][Full Text] [Related]
20. Gamma-Chain Receptor Cytokines & PD-1 Manipulation to Restore HCV-Specific CD8
Peña-Asensio J; Calvo H; Torralba M; Miquel J; Sanz-de-Villalobos E; Larrubia JR
Cells; 2021 Mar; 10(3):. PubMed ID: 33802622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
